Pioneering research to identify novel targets and treatments for animal cancers
We are dedicated to extending the groundbreaking research on biomarker discovery from Cancer Antibodies Inc. to identify novel targets for animal cancers. Our mission is to improve diagnosis, treatment, and outcomes for animals with cancer through innovative research and collaboration.
By leveraging advanced technologies and cross-species comparative oncology, we aim to develop more effective and less invasive treatment options for our animal companions.
Identifying unique biomarkers specific to animal cancers to enable earlier detection and more accurate diagnosis.
Developing targeted treatment approaches that focus on the molecular mechanisms driving cancer in animals.
Studying similarities between human and animal cancers to accelerate discoveries that benefit both.
Researching supportive care strategies to improve comfort and quality of life for animals undergoing cancer treatment.